On August 16-17, 2024, the 1st International African Helicobacter and Microbiota Study Group Inaugural Conference took place in Cape Town, South Africa. During the event, recognition was awarded to four scientists for their support, one of whom was Mārcis Leja, Director of the Institute of Clinical and Preventive Medicine at the University of Latvia.

This group was established two years ago in Nigeria, following the good experience of Europe, specifically modeled after the European Helicobacter and Microbiota Study Group. Two representatives from the European group, including one from Latvia, Professor Mārcis Leja, participated in its founding. Following the group's establishment, work began on developing the first African guidelines, with European representatives also participating in this effort.

The document was published earlier this year in the journal Digestive Diseases. This year, the conference saw broader representation from countries outside Africa, including scientists from Japan and the United States. The authors of the group's initiatives awarded their recognition to four guests for their support of the African countries' initiative, one of whom was M. Leja. The experience, including that of Latvia, which experts are ready to share with specialists on the African continent, was discussed. In his report, M. Leja provided an overview of the progress of the GISTAR, Eurohelican, TOGAS, and EUCanSCreen projects.
 

Share